Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Darcy

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|December 30, 2014
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: a Surveillance, Epidemiology and End Results studyWilliam J Lowery, Michael P Stany, Neil T Phippen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group studyCarol Aghajanian, Michael W Sill, Kathleen M Darcy, et al.
Gynecologic Oncology|September 10, 2011
The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group studyAngeles Alvarez Secord, Kathleen M Darcy, Alan Hutson, et al.
Biochemical and Biophysical Research Communications|November 29, 2015
Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1ANicholas W Bateman, Yutaka Shoji, Kelly A Conrads, et al.
Gynecologic Oncology|July 17, 2012
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group studyD Scott McMeekin, Michael W Sill, Kathleen M Darcy, et al.
The International Journal of Eating Disorders|August 23, 2014
Central coherence in adolescents with bulimia nervosa spectrum eating disordersAlison M Darcy, Kathleen Kara Fitzpatrick, Stephanie M Manasse, et al.
Gynecologic Oncology|March 11, 2009
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group StudyJohn Farley, Sartoru Fuchiuji, Kathleen M Darcy, et al.
Gynecologic Oncology|April 29, 2025
Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry studyCaitlin R Johnson, Chinmayi Aryasomayajula, Alex A Francoeur, et al.
Eating Disorders|June 26, 2014
Validation of a six-item male body image concerns scale (MBICS)Hannah L Weisman, Elaine Patten, Marcus Montanez-Leaks, et al.
Gynecologic Oncology|January 1, 2016
Nestin: A biomarker of aggressive uterine cancersErica R Hope, Paulette Mhawech-Fauceglia, Tanja Pejovic, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|December 30, 2014
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: a Surveillance, Epidemiology and End Results studyWilliam J Lowery, Michael P Stany, Neil T Phippen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group studyCarol Aghajanian, Michael W Sill, Kathleen M Darcy, et al.
Gynecologic Oncology|September 10, 2011
The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group studyAngeles Alvarez Secord, Kathleen M Darcy, Alan Hutson, et al.
Biochemical and Biophysical Research Communications|November 29, 2015
Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1ANicholas W Bateman, Yutaka Shoji, Kelly A Conrads, et al.
Gynecologic Oncology|July 17, 2012
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group studyD Scott McMeekin, Michael W Sill, Kathleen M Darcy, et al.
The International Journal of Eating Disorders|August 23, 2014
Central coherence in adolescents with bulimia nervosa spectrum eating disordersAlison M Darcy, Kathleen Kara Fitzpatrick, Stephanie M Manasse, et al.
Gynecologic Oncology|March 11, 2009
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group StudyJohn Farley, Sartoru Fuchiuji, Kathleen M Darcy, et al.
Gynecologic Oncology|April 29, 2025
Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry studyCaitlin R Johnson, Chinmayi Aryasomayajula, Alex A Francoeur, et al.
Eating Disorders|June 26, 2014
Validation of a six-item male body image concerns scale (MBICS)Hannah L Weisman, Elaine Patten, Marcus Montanez-Leaks, et al.
Gynecologic Oncology|January 1, 2016
Nestin: A biomarker of aggressive uterine cancersErica R Hope, Paulette Mhawech-Fauceglia, Tanja Pejovic, et al.
Pageof 23